Grants from National Institutes of Health

12,801 opportunities — 399 currently open. Filter open grants →

Non-Viral Technologies for in vivo Delivery of Genome Editors (R43/R44 Clinical Trial Not Allowed)

Archived
Closes: Jan 5, 2022

Non-Viral Technologies for in vivo Delivery of Genome Editors (R41/R42 Clinical Trial Not Allowed)

Archived
Closes: Jan 5, 2022

Molecular Mechanisms of Combination Adjuvants (MMCA) (U01 Clinical Trial Not Allowed)

Archived
Closes: Jul 20, 2020

International Research in Infectious Diseases (R01 Clinical Trial Not Allowed)

Archived
Closes: Aug 19, 2022

Biomedical Technology Development and Dissemination Center (RM1 - Clinical Trial Not Allowed)

Archived
Closes: Jan 26, 2023

Developmental Centers for AIDS Research (P30 Clinical Trial Not Allowed)

Archived
Closes: Jul 28, 2022

Centers for AIDS Research (P30 Clinical Trial Not Allowed)

Archived
Closes: Jul 28, 2022

National Alzheimers Coordinating Center (U24 Clinical Trial Not Allowed)

Archived
Closes: Jun 17, 2020

Childhood Asthma in Urban Settings Clinical Research Network- Leadership Center (UM1 Clinical Trial Required)

Archived
Closes: Jun 19, 2020

Childhood Asthma in Urban Settings -Clinical Research Centers (U01 Clinical Trial Optional)

Archived
Closes: Jun 19, 2020

IDeA Networks of Biomedical Research Excellence (INBRE) (P20 Clinical Trial Optional)

Archived
Closes: May 20, 2022

Collaborative Program Grant for Multidisciplinary Teams (RM1 - Clinical Trial Optional)

Archived
Closes: Jan 27, 2023

Environmental Health Sciences Core Centers (EHSCC) (P30 Clinical Trial Optional)

Archived
Closes: Apr 14, 2022

Resource Networks for Protein Polymorphisms in Alzheimers Disease and its Related Dementias (AD/ADRD) (U24 Clinical Trial Not Allowed)

Archived
Closes: Jun 17, 2020

National Cancer Institute Program Project Applications (P01 Clinical Trial Optional)

Archived
Closes: May 7, 2023

Development of Medications to Prevent and Treat Opioid Use Disorders and Overdose (UG3/UH3) (Clinical Trial Optional)

Archived
Closes: Sep 1, 2022

HEAL Initiative: Pharmacotherapies to Reverse Opioid Overdose Induced Respiratory Depression without Central Opioid Withdrawal (Target Validation and Candidate Therapeutic Development (R61/R33 - Clinical Trial Not Allowed)

Archived
Closes: Jun 24, 2020

HEAL Initiative: Pragmatic and Implementation Studies for the Management of Pain to Reduce Opioid Prescribing (PRISM) (UG3/UH3, Clinical Trials Optional)

Archived
Closes: Jun 29, 2020

Limited Competition for the Continuation of the Diabetes Prevention Program Outcomes Study (DPPOS) Biostatistics Research Center (BRC) (Collaborative U01 Clinical Trial Required)

Archived
Closes: Jul 22, 2020

Limited Competition for the Continuation of the Diabetes Prevention Program Outcomes Study (DPPOS) Clinical Centers (Collaborative U01 Clinical Trial Required)

Archived
Closes: Jul 22, 2020